ENTRY       D00610                      Drug
NAME        Terazosin hydrochloride (USP);
            Terazosin hydrochloride hydrate (JAN);
            Hytrin (TN)
PRODUCT
  GENERIC   TERAZOSIN (Aphena Pharma Solutions - Tennessee)
            TERAZOSIN (Aphena Pharma Solutions - Tennessee)
            TERAZOSIN (Bryant Ranch Prepack)
            TERAZOSIN (Chartwell RX)
            TERAZOSIN (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals)
            TERAZOSIN (Northwind Pharmaceuticals)
            TERAZOSIN (Preferred Pharmaceuticals)
            TERAZOSIN (REMEDYREPACK)
            TERAZOSIN (REMEDYREPACK)
            TERAZOSIN (REMEDYREPACK)
            TERAZOSIN (RPK Pharmaceuticals)
            TERAZOSIN (St Mary's Medical Park Pharmacy)
            TERAZOSIN HYDROCHLORIDE (Preferred Pharmaceuticals)
FORMULA     C19H25N5O4. 2H2O. HCl
EXACT_MASS  459.1885
MOL_WEIGHT  459.9244
CLASS       Cardiovascular agent
             DG01466  Adrenergic receptor antagonist
              DG01465  alpha-Adrenergic receptor antagonist
               DG01457  alpha1-Adrenergic receptor antagonist
             DG03231  Antihypertensive
REMARK      Therapeutic category: 2149
            ATC code: G04CA03
            Chemical structure group: DG00491
            Product (DG00491): D00610<JP/US> D11585<US>
EFFICACY    Antidysuria, Antihypertensive, alpha1-Adrenergic receptor antagonist
COMMENT     Prazosin derivative
TARGET      ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]
  PATHWAY   hsa04022(146+147+148)  cGMP-PKG signaling pathway
            hsa04080(146+147+148)  Neuroactive ligand-receptor interaction
            hsa04270(146+147+148)  Vascular smooth muscle contraction
INTERACTION  
STR_MAP     map07215  alpha-Adrenergic receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G04 UROLOGICALS
               G04C DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
                G04CA Alpha-adrenoreceptor antagonists
                 G04CA03 Terazosin
                  D00610  Terazosin hydrochloride (USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Alpha-adrenergic Blocking Agents
               Terazosin
                D00610  Terazosin hydrochloride (USP)
             Genitourinary Agents
              Benign Prostatic Hypertrophy Agents
               Terazosin
                D00610  Terazosin hydrochloride (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               214  Antihypertensives
                2149  Others
                 D00610  Terazosin hydrochloride (USP); Terazosin hydrochloride hydrate (JAN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01465  alpha-Adrenergic receptor antagonist
                DG01457  alpha1-Adrenergic receptor antagonist
                 DG00491  Terazosin
                  D00610  Terazosin hydrochloride
              DG03231  Antihypertensive
               DG00491  Terazosin
                D00610  Terazosin hydrochloride
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG03231  Antihypertensive
               D00610  Terazosin hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA1
                 D00610  Terazosin hydrochloride (USP) &lt;JP/US&gt;
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01465  alpha-Adrenergic receptor antagonist
                DG01457  alpha1-Adrenergic receptor antagonist
                 DG00491  Terazosin
              DG03231  Antihypertensive
               DG00491  Terazosin
DBLINKS     CAS: 70024-40-7
            PubChem: 7847676
            ChEBI: 9446
            LigandBox: D00610
ATOM        31
            1   C8y C    31.5616  -18.9123
            2   C8y C    31.5616  -17.5048
            3   C8x C    32.7916  -19.6220
            4   C8y C    30.3553  -19.6220
            5   N5x N    30.3553  -16.8247
            6   C8x C    32.7916  -16.8247
            7   C8y C    33.9921  -18.9123
            8   N5x N    29.1488  -18.9123
            9   N1a N    30.3553  -21.0235
            10  C8y C    29.1488  -17.5048
            11  C8y C    33.9921  -17.5048
            12  O2a O    35.2223  -19.6220
            13  N1y N    27.9365  -16.8247
            14  O2a O    35.2223  -16.8247
            15  C1a C    36.4286  -18.9063
            16  C1x C    27.9365  -15.4290
            17  C1x C    26.7184  -17.5048
            18  C1a C    36.4286  -17.5167
            19  C1x C    26.7184  -14.7195
            20  C1x C    25.5119  -16.8247
            21  N1y N    25.5119  -15.4290
            22  C5a C    24.2600  -14.7132
            23  C1y C    23.0787  -15.4020
            24  O5a O    24.3238  -13.3005
            25  C1x C    23.0787  -16.8020
            26  O2x O    21.7472  -14.9694
            27  C1x C    20.9243  -16.1020
            28  C1x C    21.7472  -17.2346
            29  O0  O    41.8575  -18.0785
            30  X   Cl   41.1600  -15.7500
            31  O0  O    41.8575  -18.0785
BOND        31
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 2
            7     4   8 2
            8     4   9 1
            9     5  10 2
            10    6  11 2
            11    7  12 1
            12   10  13 1
            13   11  14 1
            14   12  15 1
            15   13  16 1
            16   13  17 1
            17   14  18 1
            18   16  19 1
            19   17  20 1
            20   19  21 1
            21    7  11 1
            22    8  10 1
            23   20  21 1
            24   21  22 1
            25   22  23 1
            26   22  24 2
            27   23  25 1
            28   23  26 1
            29   26  27 1
            30   27  28 1
            31   25  28 1
BRACKET     1    39.5500  -19.0400   39.5500  -17.3600
            1    42.6300  -17.3600   42.6300  -19.0400
            1  2
  ORIGINAL  1   29
  REPEAT    1   31
///
